No stem-cell product is FDA-approved to treat arthritis, and the best available trials suggest only slight, short-term gains in pain and function, with low certainty. If you are considering stem cell for arthritis, we suggest starting with a qualified clinician and first-line conservative care, then weighing experimental options with full informed consent.
TL;DR:
- Exercise, weight management, and education have the strongest guideline support; trials enrolled people with mild to moderate damage who had not improved with conservative care.
- Repeated mesenchymal cell injections showed better pain and function at six and twelve months than one injection, but also produced more adverse events.
- Cell sources, doses, preparation methods, and delivery techniques vary across trials, so results from one clinic’s product may not apply to another.
- The FDA links unapproved regenerative products to infection and tumor formation, and long term safety beyond twelve months remains uncertain.
- Before paying, verify registered trial status, cell source, and processing, then request written risks, outcome dates, total cost, and refund terms.
Table of Contents
- What do trials say about stem cell injections for arthritis?
- Is stem cell therapy for arthritis approved by the FDA?
- What does a stem cell joint procedure involve?
- What are the risks of stem cell treatment for joint pain?
- What works for arthritis besides stem cells?
- Who should consider it, and what should you ask a clinic?
- How we counsel patients about stem cells
- Book an evaluation with our team
- FAQ
- Sources
What do trials say about stem cell injections for arthritis?
Most of the research focuses on knee osteoarthritis. A living systematic review of 25 randomized trials concluded that stem cell injections may slightly improve pain and function for up to six months compared with placebo, though the certainty of that evidence is low because the trials were small and varied widely.
A 2025 meta-analysis of mesenchymal stem cell (MSC) trials found better WOMAC and VAS scores at 6 and 12 months than control, with hints that adipose-derived cells and higher doses did better. A 2026 review described the same pattern: promising signals, uneven quality, and ongoing trials.
Here is what makes the results hard to interpret:
- Cell sources differ: bone marrow, adipose tissue, and umbilical or other allogeneic donors are all used.
- Doses, preparation methods, and delivery techniques are not standardized.
- Many trials enrolled few participants and used different outcome measures.
- Repeat dosing complicates the picture. A network meta-analysis found that repeated MSC injections may improve pain and function at 6 and 12 months more than a single injection, but with a higher rate of adverse events.
Evidence is still described as limited: the American Academy of Orthopaedic Surgeons says there is insufficient high-level evidence to recommend routine clinical use of stem cell or growth-factor injections for knee osteoarthritis. Larger, standardized trials are what the field still needs.
Is stem cell therapy for arthritis approved by the FDA?
No. The FDA’s consumer alert on regenerative medicine states there are currently no FDA-approved stem cell products for orthopedic conditions, and that clinics advertising them as approved contradict that warning.
You will often hear a few claims from clinics:
- The product is “minimally manipulated,” so it needs no approval.
- The treatment is same-day and uses your own cells.
- The use is “homologous,” meaning the cells do the same job where they are placed.
The FDA has pushed back hard on these. Its warning letter to Dynamic Stem Cell Therapy explains that many clinic products do not meet the minimal manipulation or homologous use criteria and therefore require premarket approval.
The agency has also issued a public safety alert about unapproved exosome and stem cell products tied to serious adverse events. In practice, “unapproved” means little independent oversight of what is in the syringe, so your consent form and the clinic’s answers matter a great deal.
What does a stem cell joint procedure involve?
Procedures vary by clinic, but a typical workflow follows these steps:
- Evaluation and imaging: a clinician reviews your history, exam, and X-rays or MRI.
- Choice of cell source: your own bone marrow or fat (autologous), or in some settings donor-derived cells.
- Collection and processing: for autologous cells, a sample is drawn, often under local anesthesia or light sedation, then prepared.
- Image-guided injection: ultrasound or fluoroscopy guides the cells into the joint.
- Aftercare: brief monitoring, then discharge with activity instructions.
Expect the visit to take a few hours, and expect soreness. Many clinics advise limiting high-impact activity for a period afterward. Outcomes are usually checked at about 3, 6, and 12 months, which mirrors how the trials measured results. We have written about what 3–12 month timelines look like for spine conditions, and the same patience applies to joints.
Pro Tip: Ask for the follow-up schedule and outcome measures in writing before the procedure, so you can judge honestly whether it helped.
What are the risks of stem cell treatment for joint pain?
Any needle placed in a joint carries procedural risks: infection, bleeding, a temporary pain flare after the injection, and in rare cases septic arthritis. These are not unique to stem cells.
Product-related concerns are less certain:
- The FDA says unapproved regenerative products have been linked to infection and tumor formation.
- Processing varies from clinic to clinic, so two products with the same name may differ.
- Repeated injections raised adverse events in the network meta-analysis noted above.
- Long-term safety data past 12 months are thin, so durability and late effects remain unknown.
Serious harms have been reported in patients treated with unapproved exosome products, which the FDA regulates as drugs or biologics with no approval. Experimental treatments should come with documented informed consent, and ideally IRB or IND oversight.
What works for arthritis besides stem cells?
Guidelines are consistent here. A systematic review of clinical practice guidelines found steady “should do” recommendations for exercise, weight management, and education, while recommendations for injections were inconsistent. The CDC supports physical activity as safe and effective for reducing pain and improving function.
- Exercise and physical therapy: see how physical therapy helps arthritis without surgery.
- Weight management: body weight shapes joint pain.
- Medications and injections: NSAIDs, corticosteroid injections, hyaluronic acid, and platelet-rich plasma (PRP) each have a role, with varying evidence.
- Adjuncts: some people explore red light therapy for arthritis alongside their main plan.
Combined programs tend to give the most consistent long-term results. For more ideas, read our overview of alternative treatments for joint pain.
Who should consider it, and what should you ask a clinic?
Trial participants typically had symptoms for months, had not improved with conservative care, and had mild to moderate joint damage. When damage is advanced, surgery remains the better-supported option. NICE guidance, reproduced in the NCBI Bookshelf, treats intra-articular stem cell injections as experimental and advises using them only in research settings. You can search Clinicaltrials for regulated studies.
Bring these questions to your consultation:
- Is this a registered clinical trial or an off-label commercial service?
- What evidence do you rely on, and how strong is it?
- What is the cell source, and how is it processed?
- What is the IRB or IND status?
- What is the follow-up plan, total cost, and refund policy?
Walk away if you hear guarantees, vague product descriptions, pressure to pay upfront, or if no written consent describes the risks.
How we counsel patients about stem cells
Many patients come to us after trying several non-surgical treatments, and they are tired. We start with conservative care, set honest timelines, and agree on what “better” means before anything advanced is considered. If we discuss regenerative options, it happens with documented consent and a plain review of the evidence, including where it falls short. Shared decisions beat sales pitches.
— Felix
Book an evaluation with our team
We offer regenerative medicine, PRP, and physical therapy, and we start every visit with a thorough evaluation to decide what is appropriate for you. You can expect an exam, imaging review, a frank discussion of options, and an individualized plan. To learn more or book, visit our stem cell information page.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Do stem cells help arthritis?
They may help a little. A living systematic review found slight improvements in pain and function up to six months, but with low certainty. Results vary by cell source and protocol.
Is stem cell treatment for joint pain FDA-approved?
No. The FDA states there are no approved stem cell products for orthopedic conditions. Any clinic claiming otherwise is contradicting that warning.
What are the treatment options for knee arthritis without surgery?
Exercise, physical therapy, weight management, and education are the guideline-backed foundation. Medications and injections such as hyaluronic acid or PRP can be added depending on your situation.
How does PRP compare with stem cell injections for arthritis?
Both are regenerative approaches, but they are different products with different evidence bases. Ask any clinic which studies support the specific treatment they recommend for your joint.
